Tau PET is central to Alzheimer's diagnosis and trial selection. But does tracer choice matter? The HEAD study set out to answer that. 682 participants, both Flortaucipir and MK6240, across the Alzheimer's spectrum. Out today in @TheLancet.
Article link: https://t.co/BUCVevtJJ0
Contingency of Plasma Dementia Biomarkers on Cognitive Profiles for Prognosis of Incident Dementia: The ARIC Study https://t.co/CNvE97eNdX
#NeuroTwitter#Dementia
🚨 Check out our recent study on @GreenJournal 🧠 @andreibieger & colleagues developed an algorithm to compare the outcomes of different Alzheimer’s disease diagnostic criteria in the same group of individuals 🪢👇 https://t.co/spJGlp0pp1
1/Time is brain!
So you don’t have time to struggle w/that stroke alert head CT.
If there’s no flow, what are the things you need to know??
Here’s a thread to help you with the five main CT findings in acute stroke.
This study demonstrated that different #Alzheimer disease (AD) diagnostic criteria may lead to different diagnoses across the AD continuum. Divergent diagnoses were made mostly in asymptomatic individuals and when only 1 AD biomarker was positive. https://t.co/vyGF0xEiUz
🚨The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test🚨in my accompanying Editorial @GreenJournal as supported by the excellent & necessary collaborative study led by @erzimmer@zimmerneurolab et al!
Special thx to Melissa Paretsky!
https://t.co/kDD1VY1sF3
It is out! In a massive team effort led by @giovannacollar, we systematically reviewed and meta-analyzed 3k papers evaluating the GABAergic system in AD! @molpsychiatry https://t.co/3tOVvN2q9z
Very proud to present the Brazilian work at #AAIC23! The @zimmerneurolab has now officially 5⃣ years! Thanks to all the students and collaborators who have contributed to building a strong scientific culture for studying Alzheimer's in Porto Alegre! See you all in 🇳🇱! #ENDALZ
From Porto Alegre to Amsterdam 🇧🇷 ✈️🇳🇱
Looking forward to presenting 22 works at #AAIC23, the largest and most diverse international meeting dedicated to advancing dementia research. @alzassociation@ISTAART#ZLabAAIC23
The work by @LabPascoal led @BellaverBruna just out in @NatureMedicine has attracted much attention 👉 The question of whether many Aβ+ CU individuals do not develop downstream tau pathology needs to be addressed! We are honored to have contributed https://t.co/FBBImCOHCK 1/+
Microglia (red) and astrocytes (green) interact with dying neurons (pTau, yellow) at different stages of cell death.
Credits: @DaniBeckman#neuroscience
I'm presenting at #AAIC23, the largest and most influential international conference on dementia science. Join me and explore opportunities to accelerate your work and elevate your career.
Register now to save! Early bird registration ends May 12.
https://t.co/zWOz87uQdA
Don't miss the most influential international meeting dedicated to advancing dementia science.
Register for #AAIC23 now to save! Early bird registration ends May 12.
https://t.co/pGhGl4ftf6
Who doesn't love a good graph of biomarkers abnormality in AD, right!?
Wondering when a good one compiling the main glial response to AD was coming out? We did two!
Check it in the work led by @andreibieger
👉https://t.co/blHXclHBhX
🚨 Super excited to announce our new revision paper "Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer’s Disease Continuum" at @springerpub's Journal of Prevention of Alzheimer's Disease 🧠. Check it out at: https://t.co/uULT8Jyrtv @zimmerneurolab